Detalhe da pesquisa
1.
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
Lancet
; 403(10435): 1460-1471, 2024 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554725
2.
Emerging therapies in Ewing sarcoma.
Curr Opin Oncol
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38775200
3.
Incidence and survival of soft tissue sarcoma in England between 2013 and 2017, an analysis from the National Cancer Registration and Analysis Service.
Int J Cancer
; 152(9): 1789-1803, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541754
4.
Axitinib in patients with advanced/metastatic soft tissue sarcoma (Axi-STS): an open-label, multicentre, phase II trial in four histological strata.
Br J Cancer
; 129(9): 1490-1499, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37684354
5.
Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial).
BMC Cancer
; 22(1): 629, 2022 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35672690
6.
Current approaches to management of bone sarcoma in adolescent and young adult patients.
Pediatr Blood Cancer
; 69(2): e29442, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34767314
7.
Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study.
Lancet Oncol
; 22(9): 1312-1321, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416158
8.
SARC025 arms 1 and 2: A phase 1 study of the poly(ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma.
Cancer
; 127(8): 1301-1310, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33289920
9.
Current questions in bone sarcomas.
Curr Opin Oncol
; 30(4): 252-259, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29782347
10.
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial.
Lancet Oncol
; 18(10): 1397-1410, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28882536
11.
EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.
J Pathol
; 239(3): 320-34, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27102572
12.
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.
Lancet Oncol
; 17(10): 1396-1408, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27569442
13.
Follow-up practices for high-grade extremity Osteosarcoma.
BMC Cancer
; 16: 301, 2016 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27154292
14.
Cancer care and well-being in adolescents and young adults during the coronavirus disease 2019 pandemic: A UK sarcoma perspective.
Cancer
; 126(24): 5359-5360, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32986243
15.
Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?
BMC Cancer
; 14: 23, 2014 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24422949
16.
Primary retroperitoneal sarcoma: A comparison of survival outcomes in specialist and non-specialist sarcoma centres.
Eur J Cancer
; 188: 20-28, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37178646
17.
Bad to the Bone: Emerging Approaches to Aggressive Bone Sarcomas.
Am Soc Clin Oncol Educ Book
; 43: e390306, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37220319
18.
A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?
Cancer Treat Rev
; 120: 102625, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738712
19.
Incidence and survival of malignant bone sarcomas in England 1979-2007.
Int J Cancer
; 131(4): E508-17, 2012 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21913189
20.
Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study.
Cancer
; 118(7): 1856-67, 2012 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21887680